Literature DB >> 15456931

Brain injury-dependent expression of activity-dependent neuroprotective protein.

Roy Zaltzman1, Alexander Alexandrovich, Sara M Beni, Victoria Trembovler, Esther Shohami, Illana Gozes.   

Abstract

Activity-dependent neuroprotective protein (ADNP), a crucial brain development factor, contains a unique sequence, termed NAPVSIPQ, which protects mice against closed head injury (CHI). The aim of this study was to determine whether CHI affects ADNP mRNA expression in the injured brain hemisphere. Male C57JBL/6J mice were subjected to CHI. Brains were removed 5 h, 24 h, 7 d, and 29 d post-CHI. A comparison was made between ADNP mRNA in the injured versus the noninjured hemisphere using real-time polymerase chain reaction. A nonsignificant change (p >0.05) was found 5 h, 24 h, and 7 d post-CHI. However, a significant increase (p <0.05) in ADNP mRNA expression was detected in the injured cerebral hemisphere 29 d post-CHI. The data presented may be associated with ADNP's crucial involvement in brain development and response to injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456931     DOI: 10.1385/JMN:24:2:181

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  31 in total

Review 1.  Neuroprotective peptide drug delivery and development: potential new therapeutics.

Authors:  I Gozes
Journal:  Trends Neurosci       Date:  2001-12       Impact factor: 13.837

Review 2.  Neurogenesis and brain injury: managing a renewable resource for repair.

Authors:  Anna F Hallbergson; Carmen Gnatenco; Daniel A Peterson
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

3.  FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice.

Authors:  Shinichi Yoshimura; Tetsuyuki Teramoto; Michael J Whalen; Michael C Irizarry; Yasushi Takagi; Jianhua Qiu; Jun Harada; Christian Waeber; Xandra O Breakefield; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

4.  NAP accelerates the performance of normal rats in the water maze.

Authors:  Illana Gozes; Roy Alcalay; Eliezer Giladi; Albert Pinhasov; Sharon Furman; Douglas E Brenneman
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

5.  Astrocytic factors down-regulate the expression of major histocompatibility complex-class-II and intercellular adhesion molecule-1 on human monocytes.

Authors:  N P Hailer; B Glomsda; R A Blaheta
Journal:  Neurosci Lett       Date:  2001-01-26       Impact factor: 3.046

Review 6.  Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.

Authors:  M Delgado; C Abad; C Martinez; M G Juarranz; A Arranz; R P Gomariz; J Leceta
Journal:  J Mol Med (Berl)       Date:  2001-10-17       Impact factor: 4.599

7.  Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and function.

Authors:  S M Tan; R H Hyland; A Al-Shamkhani; W A Douglass; J M Shaw; S K Law
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

8.  Cloning and characterization of the human activity-dependent neuroprotective protein.

Authors:  R Zamostiano; A Pinhasov; E Gelber; R A Steingart; E Seroussi; E Giladi; M Bassan; Y Wollman; H J Eyre; J C Mulley; D E Brenneman; I Gozes
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

9.  PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.

Authors:  T Glaser; L Jepeal; J G Edwards; S R Young; J Favor; R L Maas
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

Review 10.  From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division.

Authors:  Illana Gozes; Inna Divinsky; Inbar Pilzer; Mati Fridkin; Douglas E Brenneman; Avron D Spier
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

View more
  9 in total

Review 1.  Neuroprotective protein and carboxypeptidase E.

Authors:  Hisatsugu Koshimizu; Vladimir Senatorov; Y Peng Loh; Illana Gozes
Journal:  J Mol Neurosci       Date:  2009-01-23       Impact factor: 3.444

2.  Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.

Authors:  Rafael Fernandez-Montesinos; Manuel Torres; David Baglietto-Vargas; Antonia Gutierrez; Illana Gozes; Javier Vitorica; David Pozo
Journal:  J Mol Neurosci       Date:  2009-10-21       Impact factor: 3.444

3.  Activity-dependent neuroprotective protein modulates its own gene expression.

Authors:  Moutasem S Aboonq; Sylvia A Vasiliou; Kate Haddley; John P Quinn; Vivien J Bubb
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

4.  Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic death.

Authors:  Soraya Scuderi; Agata Grazia D'Amico; Alessandro Castorina; Concetta Federico; Giuseppina Marrazzo; Filippo Drago; Claudio Bucolo; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2014-02-02       Impact factor: 3.444

5.  Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38.

Authors:  Min Li; Csaba David; Toshiteru Kikuta; Aniko Somogyvari-Vigh; Akira Arimura
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance.

Authors:  Shmuel Mandel; Irit Spivak-Pohis; Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-02-20       Impact factor: 3.444

7.  Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.

Authors:  Eliezer Giladi; Joanna M Hill; Efrat Dresner; Conor M Stack; Illana Gozes
Journal:  J Mol Neurosci       Date:  2007-10-02       Impact factor: 3.444

8.  NAP reduces murine microvascular endothelial cells proliferation induced by hyperglycemia.

Authors:  Agata Grazia D'Amico; Soraya Scuderi; Grazia Maugeri; Sebastiano Cavallaro; Filippo Drago; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2014-05-30       Impact factor: 3.444

9.  Tau and caspase 3 as targets for neuroprotection.

Authors:  Anat Idan-Feldman; Regina Ostritsky; Illana Gozes
Journal:  Int J Alzheimers Dis       Date:  2012-05-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.